Home
TVRD
TVRD News

Latest Tvardi Therapeutics Inc. Common Stock (TVRD) News on October 8, 2025

Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks

TipRanks

4 months ago

Oppenheimer Predicts Up to ~550% Jump for These 2 ‘Strong Buy’ Stocks

Business Wire

4 months ago

Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis

Business Wire

5 months ago

Tvardi Therapeutics to Participate in Upcoming Investor Conferences

Business Wire

5 months ago

Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update

Business Wire

5 months ago

Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference

Share on Social Networks: